MedPath
TGA Approval

PROHANCE gadoteridol 4189.5mg/15mL injection syringe (72675)

72675

PROHANCE gadoteridol 4189.5mg/15mL injection syringe

Bracco Pty Ltd

September 1, 2000

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2012-CMI-01297-3

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-PI-02764-3

Active Ingredients

gadoteridol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROHANCE gadoteridol 4189.5mg/15mL injection syringe (72675) - TGA 批准文号 | MedPath